APGN
Apexigen, Inc. Common Stock
APGN
APGN
Delisted
APGN was delisted on the 22nd of August, 2023.
17 hedge funds and large institutions have $1.37M invested in Apexigen, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Holders
17
Holding in Top 10
1
Calls
–
Puts
$9K
Top Buyers
| 1 | +$12.6K | |
| 2 | +$3.92K | |
| 3 | +$689 | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$150 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| 1 | -$75K | |
| 2 | -$11K | |
| 3 | -$7.77K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$5.97K |
| 5 |
Two Sigma Investments
New York
|
-$5.14K |
